Li Xiao-Li, Yan Tie-Kun, Li Hong-Fen, Xu Peng-Cheng, Jia Jun-Ya, Wei Li, Shang Wen-Ya, Lin Shan
Department of Nephrology, General Hospital of Tianjin Medical University, Tianjin, 300052, China.
Clin Rheumatol. 2014 Jan;33(1):145-8. doi: 10.1007/s10067-013-2406-0. Epub 2013 Oct 9.
Membranous nephropathy (MN) is a rare manifestation of IgG4-related disease. Interestingly, the significance of IgG4 has also been documented in idiopathic MN (IMN). Previous studies reported that urine IgG4/IgG ratios were significantly higher in IMN compared with other kinds of nephropathy, indicating that impairment of charge selectivity barrier seemed to be an obvious characteristic of IMN. Although high blood concentration of IgG4 is very common in IgG4-related MN, no study about the urine IgG4 has been described before. Here, we present a 55-year-old male with IgG4-related MN. Complete remission of proteinuria was promptly achieved by glucocorticoid treatment without immunosuppressant. Consistent with previous reports, the serum antibody against M-type phospholipase A2 receptor was negative. Surprisingly, although the blood concentration of IgG4/IgG reached as high as 36 %, the urine concentration of IgG4/IgG was only 5 %. The calculated ratio of the renal clearance of IgG4 to IgG of this patient (0.15) was obviously lower than that of five patients with IMN (0.53∼0.81). We speculated that this phenomenon might be a clue of the different pathogenesis between IgG4-related MN and IMN.
膜性肾病(MN)是IgG4相关性疾病的一种罕见表现。有趣的是,IgG4在特发性MN(IMN)中的意义也已得到证实。先前的研究报道,与其他类型的肾病相比,IMN患者尿中IgG4/IgG比值显著更高,这表明电荷选择性屏障受损似乎是IMN的一个明显特征。虽然IgG4相关MN患者血液中IgG4浓度升高很常见,但此前尚无关于尿IgG4的研究报道。在此,我们报告一例55岁的IgG4相关MN男性患者。通过糖皮质激素治疗,未使用免疫抑制剂,蛋白尿迅速完全缓解。与先前报道一致,抗M型磷脂酶A2受体血清抗体为阴性。令人惊讶的是,尽管血液中IgG4/IgG浓度高达36%,但尿中IgG4/IgG浓度仅为5%。该患者IgG4与IgG的肾清除率计算比值(0.15)明显低于5例IMN患者(0.53~0.81)。我们推测,这种现象可能是IgG4相关MN与IMN发病机制不同的一个线索。